Learning outcomes
By the end of this lesson you should be able to: describe the metabolism of bilirubin and say what is different about the newborn; distinguish physiological jaundice from jaundice that must be investigated, on the timing, the rate of rise and the baby's state; separate unconjugated from conjugated hyperbilirubinaemia and name the causes of each; apply the age- and gestation-specific thresholds for phototherapy and exchange transfusion; describe the features and the management of rhesus and ABO haemolytic disease; and state the acute and chronic neurological injury that uncontrolled bilirubin causes.
Prerequisites
Lesson 2 and BCHM 101 module 2 — haem catabolism, the hepatic conjugation of xenobiotics and the biliary tree. Jaundice is a biochemical disturbance that is clinically invisible until it becomes a poisoning of the brain.
The big idea
Bilirubin is the waste product of haem breakdown: red cells, myoglobin and cytochromes are catabolised by haem oxygenase and biliverdin reductase to unconjugated bilirubin, which is insoluble in water and therefore carried in the plasma bound to albumin. The liver conjugates it with glucuronic acid through UDP-glucuronosyltransferase 1A1 to make water-soluble bilirubin diglucuronide, which is excreted in bile, converted by gut bacteria to stercobilinogen, and passed in the stool; a fraction is reabsorbed and appears in the urine as urobilinogen.
Watch outThe newborn's bilirubin load is enormous for its liver: a term infant makes about 8 to 10 mg of bilirubin per kilogram a day, about twice the adult rate per kilogram, with an immature conjugation pathway and an almost sterile gut that cannot break the reabsorbed bilirubin down. That is why the bilirubin normally rises to a peak on the third to fourth day and falls again over the following week.
Worked example 1: physiological versus pathological jaundice
| Feature | Physiological jaundice | Pathological jaundice — investigate |
|---|---|---|
| Onset | After the first 24 hours of life | Within the first 24 hours — always pathological |
| Rate of rise | Below about 8 µmol/L per hour | Above 5 mg/dL a day (8 µmol/L an hour) |
| Peak | Day 3 to 5, then falling | Rising after day 5, or continuing to rise after the expected peak |
| Duration | Settles by 2 weeks in a term infant and 3 weeks in a preterm infant | Persists beyond those limits, or is conjugated from the start |
| Conjugated fraction | Always below the conjugated threshold | Any conjugated fraction over about 20 µmol/L |
| The baby | Well, alert, feeding, gaining weight | Poor feeding, lethargy, hypotonia, high-pitched cry, fever, hepatosplenomegaly, sepsis |
| Commonest causes | Newborn erythrocyte turnover, immature UDP-glucuronosyltransferase, breast milk and enterohepatic reabsorption | Haemolysis, infection, sepsis, metabolic disease, biliary obstruction |
Watch outJaundice in the first 24 hours of life is never physiological. It is haemolysis until proven otherwise — rhesus or ABO incompatibility, glucose-6-phosphate dehydrogenase deficiency, pyruvate kinase deficiency or spherocytosis — and it demands a same-day bilirubin, a blood group and a direct antiglobulin (Coombs) test, a full blood count and a smear.
Worked example 2: the causes, by mechanism
| Timing | Mechanism | Causes |
|---|---|---|
| First 24 hours | Haemolysis | Rhesus haemolytic disease, ABO incompatibility, glucose-6-phosphate dehydrogenase deficiency, hereditary spherocytosis, pyruvate kinase deficiency |
| Day 2 to 7 | Increased bilirubin load and immature conjugation | Physiological jaundice, breastfeeding failure jaundice, cephalohaematoma, polycythaemia, sepsis |
| Day 7 onward | Prolonged unconjugated | Breast milk jaundice, ongoing sepsis, hypothyroidism, upper intestinal obstruction, cholestasis |
| Any time | Conjugated — biliary obstruction or hepatocellular | Biliary atresia, choledochal cyst, neonatal hepatitis, galactosaemia, alpha-1-antitrypsin deficiency, total parenteral nutrition cholestasis, cystic fibrosis |
Worked example 3: thresholds, treatment and kernicterus
Every jaundiced baby is treated against an age- and gestation-specific threshold chart rather than against a single number, because the risk rises with the bilirubin concentration, the duration of the exposure, and the infant's albumin, acidosis, sepsis and gestational age. The values below are approximations for a well infant of 38 weeks or more without risk factors, given to show the shape of the chart; the real chart is used, with a lower threshold at 35 to 37 weeks and in any infant with a lower threshold risk score. Multiply micromoles by 0.058 to convert to mg/dL.
| Age | Phototherapy threshold — well term infant (approx.) | Exchange transfusion threshold (approx.) |
|---|---|---|
| 24 hours | about 100 µmol/L (6 mg/dL) | about 300 µmol/L (17 mg/dL) |
| 48 hours | about 140 µmol/L (8 mg/dL) | about 360 µmol/L (21 mg/dL) |
| 72 hours | about 180 µmol/L (10 to 11 mg/dL) | about 420 µmol/L (24 to 25 mg/dL) |
| 96 hours and later | about 200 µmol/L (12 mg/dL) | about 450 µmol/L (26 mg/dL) |
| Treatment | How it works | Practical points |
|---|---|---|
| Phototherapy | Blue light of 425 to 475 nm converts bilirubin in the skin to water-soluble lumirubin, which is excreted without conjugation | Intensive means maximal irradiance, maximal skin exposed, a warm cot, eye protection, and frequent feeding; therapeutic efficiency falls once the threshold is crossed |
| Exchange transfusion | A double-volume exchange (2 x 60 to 80 mL/kg) removes bilirubin and antibodies and corrects anaemia | Reserved for a bilirubin at or above the exchange threshold despite intensive phototherapy; risks are catheter injury, thrombosis, hypocalcaemia, hypoglycaemia and transfusion reaction |
| Intravenous immunoglobulin | Blocks the Fc receptor and reduces haemolysis in immune haemolysis | 0.5 g/kg in rhesus or ABO disease with a rising bilirubin despite phototherapy |
| Treat the cause | Antibiotics for sepsis, thyroxine for hypothyroidism, surgically created biliary drainage for biliary atresia | A conjugated jaundice is a surgical referral, and the window for a successful Kasai is before 8 weeks of age |
Watch outThere is no safe bilirubin concentration. The risk is determined by the interaction between the concentration and the albumin, the pH, the albumin-binding drugs and the sepsis, which is why a septic or acidotic infant is treated at a lower threshold than a thriving one.
Common mistakes
Watch outWaiting for a visual assessment to decide. Clinical jaundice is not reliably seen until the bilirubin is high and is invisible under artificial light, so every baby who looks jaundiced in the first 24 hours, or who looks significantly jaundiced at any age, has a transcutaneous measurement or a serum bilirubin taken.
Watch outReassuring a family that prolonged jaundice will settle. Any jaundice beyond 2 weeks in a term infant or 3 weeks in a preterm infant needs the stool colour inspected and a conjugated fraction measured, because biliary atresia is best treated surgically before 8 weeks of age.
Watch outStopping breastfeeding to treat jaundice. Breast milk jaundice is benign, breastfeeding failure jaundice is treated by increasing the milk the baby receives, and the interruption of breastfeeding is a harm without a benefit.
Watch outTreating a conjugated jaundice with phototherapy alone. Conjugated bilirubin is already water soluble and is not a substrate for phototherapy; the child needs a diagnosis of the obstruction.
Check your understanding
List the six features that make neonatal jaundice pathological rather than physiological.
What investigations are needed in an infant who is jaundiced within the first 24 hours of life?
What is the danger of bilirubin crossing the blood-brain barrier, and which infants are at the greatest risk?
Multiple choice
A 12-hour-old infant is visibly jaundiced. Which statement is correct?
A 3-week-old infant has yellow sclera, dark urine and pale chalky stools. What is the priority?
How does phototherapy lower the bilirubin concentration?
A rhesus-negative mother has a rhesus-positive infant and had no anti-D prophylaxis. What is the mechanism of the neonatal haemolysis?
Which finding is most consistent with breast milk jaundice?
Summary and next
The newborn carries a large bilirubin load through an immature conjugation pathway, so a rising unconjugated bilirubin is expected, and jaundice becomes pathological when it starts before 24 hours, rises faster than about 8 µmol/L an hour, persists beyond the second or third week, becomes conjugated, or is accompanied by an unwell infant. Treatment is against an age- and gestation-specific threshold chart — phototherapy at the phototherapy threshold, an exchange transfusion at or above the exchange threshold — and the risk is not the number alone but the number against the albumin, the pH and the sepsis, because the injury is kernicterus. Conjugated jaundice is a different disease: biliary atresia is the one diagnosis that must not be missed, and the surgical window closes before 8 weeks of age.
Next: the two commonest causes of a noisy, distressed child — bronchiolitis and croup — and the airway emergencies that must never be confused with them.